Daiichi Sankyo
Singh is the former chairman and CEO of Ranbaxy Laboratories, an Indian pharmaceutical company that was sold to Japanese drugmaker Daiichi Sankyo. Singh resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit.